AI news impact · US stocks

Eli Lilly and Company (LLY) news impact

On 2026-11-18 Wave Radar's AI rated the news on Eli Lilly and Company as neutral (impact score +25%).

Barclays raised Eli Lilly's price target to $1,550 on 39% Q3 revenue growth, and Lilly participated in VitriVax's $87M round; a vendor suffered a breach, but Lilly's internal systems were safe.

Direction
Neutral
Impact score
+25%
Confidence
80%
Headlines read
5
Date
2026-11-18
Open LLY news in Wave Radar

AI assessment

Lilly's growth outlook remains intact with bullish analyst revisions and pipeline investments, while the third-party breach appears contained without internal intrusion.

Sector impact

Lilly's continued revenue strength and pipeline investments maintain positive sentiment across the large-cap pharmaceuticals and biopharma landscape.

Headlines the AI read

Rating history

One rating per trading day the stock was covered.

More on Eli Lilly and Company

LLY valuation · LLY gamma exposure

How the rating works

After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.